Simvastatin as a Potential Disease-Modifying Therapy for Patients with Parkinson’s Disease: Rationale for Clinical Trial, and Current Progress

  • Camille B. Carroll
  • , Richard K.H. Wyse*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

11 Downloads (Pure)
Original languageEnglish
Number of pages0
JournalJournal of Parkinson's Disease
Volume0
Issue number0
Early online date13 Oct 2017
DOIs
Publication statusPublished - 13 Oct 2017

Cite this